A phase II trial of sorafenib in relapsed and unresectable high-grade osteosarcoma after failure of standard multimodal therapy: an Italian Sarcoma Group study
Titel:
A phase II trial of sorafenib in relapsed and unresectable high-grade osteosarcoma after failure of standard multimodal therapy: an Italian Sarcoma Group study
Auteur:
Grignani, G. Palmerini, E. Dileo, P. Asaftei, S.D. D’Ambrosio, L. Pignochino, Y. Mercuri, M. Picci, P. Fagioli, F. Casali, P.G. Ferrari, S. Aglietta, M.